• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

Ar­cus grabs US rights to a WuXi-built PD-1 as sec­ond wave of check­points builds

8 years ago
R&D
Pharma

Blue­Rock ex­pands Toron­to ops; Uni­ty brings B round to $151M; No­var­tis backs Al­tim­mune's $15M raise

8 years ago
News Briefing

Atre­ca bags $35M B round for next-gen im­muno-on­col­o­gy drug pipeline

8 years ago
Financing

Price goug­ing on drugs? Shkre­li's ju­ry se­lec­tion process re­veals some deep pub­lic anger

8 years ago
People
Pharma

Aerie boost­ed as Valean­t's trou­bled Tam­pa fa­cil­i­ty looks like it's com­ing out of re­hab

8 years ago
Pharma

Top UCSF sci­en­tist Shaun Cough­lin joins mi­gra­tion to Big Phar­ma, leap­ing to No­var­tis

8 years ago
People

Novo's semaglu­tide hand­i­ly whips Eli Lil­ly's Trulic­i­ty in a PhI­II di­a­betes show­down

8 years ago
R&D

J&J's Alex Gorsky re­vers­es course and jumps ship — just as Trump scut­tles top CEO groups

8 years ago
Pharma

Take­da inks dis­cov­ery pact with Stan­ford; Jounce taps Ari­ad vet Cole as new CBO

8 years ago
News Briefing

New study of FDA cites the flaws be­hind rapid-fire can­cer drug OKs

8 years ago
Pharma

Cel­gene-part­nered An­ten­gene preps new Chi­na deals as $21M round lands

8 years ago
China
Pharma

Feds of­fer up a new bonus plan for the R&D work they of­ten pay for

8 years ago
Pharma

The big re­vamp at Glax­o­SmithK­line R&D in­cludes a new col­lab­o­ra­tion on AI

8 years ago
Startups
AI

With a big stake in hand, Saman­tha Du files for $115M IPO for Zai Lab

8 years ago
Financing
China

Bris­tol-My­ers shares sink af­ter an­oth­er set­back for its im­muno-on­col­o­gy fran­chise drugs

8 years ago
R&D

As Trump lash­es out at Fra­zier again, J&J's Alex Gorsky says he's not aban­don­ing pres­i­den­t's coun­cil

8 years ago
Pharma

Biosims mak­ing slow progress bat­tling block­busters for mar­ket share; Fi­bro­Gen rais­ing $300M

8 years ago
News Briefing

Drug de­vel­op­ers face in­creas­ing­ly risky tightrope walk be­tween top-line re­sults and hard da­ta

8 years ago
R&D

With an eye on the FDA, Lex­i­con and Sanofi line up more pos­i­tive da­ta on di­a­betes drug

8 years ago
R&D

What's worth $500M-plus? The Big 6 deals of Q2 show you where the mon­ey is — and is­n't

8 years ago
Pharma

Is Ama­zon plan­ning to dis­rupt the $560B pre­scrip­tion drug mar­ket?

8 years ago
Pharma

Trump's re­newed broad­sides on drug pric­ing did­n't even dent bio­phar­ma this time

8 years ago
Bioregnum
Opinion

J&J beefs up neu­ro pipeline, bags a new de­pres­sion drug from Cere­cor in $45M deal

8 years ago
Pharma

Cel-Sci shares jump af­ter FDA lifts hold; New up­start is look­ing for Eu­ro mar­ket­ing pacts with biotech

8 years ago
News Briefing
First page Previous page 1090109110921093109410951096 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Log in to your account

email

password

Endpoints News

request login link

Enter the email associated to with your Endpoints account, and we'll send you a one-time login link (no password needed). The link expires after 24 hours.

email

Endpoints News

reset password

Enter the email associated to with your Endpoints account, and we'll send you a link to reset your password. The link expires after 24 hours and can only be used once.

email

Endpoints News

Sign up for free to read a limited number of articles each month.

About You

Newsletter Interests

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Want unlimited access? Sign up for a premium subscription plan.